Back

Characteristics and prognosis of the catecholamine induced QT prolongation syndrome

28 August 2022 (09:20 - 09:30)
Organised by:
Congress Presentation Part of: Primary arrhythmia syndromes - Device treatment Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Vincent Probst

University Hospital of Nantes, Nantes (France)

3 More presentations in this session

Presentation thumbnail
T-wave alternans poorly prognostic in primary prophylactic ICD patients: A prospective EU-CERT-ICD study
Doctor A. Pelli (Oulu, FI)
Abstract Slides Video
Presentation thumbnail
Three dimensional modelling of mutant Kir2.1 channel PIP2 interactions help stratify arrhythmia severity in Andersen Tawil syndrome type 1
Mrs L. Gutierrez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Catecholaminergic polymorphic ventricular tachycardia: risk modulators in patients treated with beta-blockers
Doctor D. Kukavica (Pavia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Primary arrhythmia syndromes - Device treatment

The Event

Event poster

ESC Congress 2022

28 August 2022 09:20 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence and characteristics of the catecholamine induced QT prolongation syndrome
thumbnail
Congress Presentation
Prevalence and characteristics of the catecholamine induced QT prolongation syndrome
thumbnail
Congress Presentation
Sudden cardiac death abortion as a clinical presentation of long QT syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources